We are live on
!
Find out more
CCM
Carderock Capital Management Portfolio holdings
AUM
$456M
1-Year Est. Return
31.89%
This Fund
S&P 500
This Quarter
Est. Return
+2.9%
1 Year Est. Return
+31.89%
3 Year Est. Return
+88.65%
5 Year Est. Return
+111.4%
10 Year Est. Return
+513.53%
AUM
$382M
AUM Growth
+$25.4M
(+7.1%)
Cap. Flow
+$20.9M
Cap. Flow
% of AUM
5.47%
Top 10 Holdings %
Top 10 Hldgs %
30.06%
Holding
75
New
7
Increased
35
Reduced
14
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stryker
SYK
|
+$6.37M |
| 2 |
Eli Lilly
LLY
|
+$6.21M |
| 3 |
Intuitive Surgical
ISRG
|
+$5.23M |
| 4 |
Watsco Inc
WSO
|
+$5.1M |
| 5 |
Monolithic Power Systems
MPWR
|
+$4.04M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
West Pharmaceutical
WST
|
+$7.77M |
| 2 |
IDEX
IEX
|
+$6.05M |
| 3 |
Pool Corp
POOL
|
+$4.7M |
| 4 |
Abbott
ABT
|
+$2.84M |
| 5 |
ANSS
Ansys
ANSS
|
+$2.65M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.65% |
| 2 | Industrials | 20.26% |
| 3 | Healthcare | 14.82% |
| 4 | Financials | 11.95% |
| 5 | Consumer Discretionary | 5.98% |
Similar funds
HFF
FIM
EGP
AWM
EIA
BRF
TCMP
FC
Carderock Capital Management's Q2 2024 Portfolio in Review
As of Q2 2024, Carderock Capital Management held 75 positions worth $382M, up 7.1% from $357M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Carderock Capital Management deployed $20.9M of net new capital in Q2 2024, opening 7 new positions and adding to 35 existing holdings. Its largest new stake was Stryker: 18,802 shares worth $6.4M.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was IDEX, an estimated $6.05M trimmed.
- Carderock Capital Management's largest Q2 2024 buy was Stryker: 18,802 shares worth $6.4M.
- Carderock Capital Management added most to Intuitive Surgical in Q2 2024, an estimated $5.23M increase.
- Carderock Capital Management's biggest Q2 2024 reduction was IDEX, cutting an estimated $6.05M.
- Carderock Capital Management fully exited West Pharmaceutical in Q2 2024, selling an estimated $7.77M.
- Carderock Capital Management's ten largest holdings make up 30% of its $382M portfolio in Q2 2024.
- Carderock Capital Management opened 7 new positions and closed 6 in Q2 2024.
- Carderock Capital Management's portfolio value rose 7.1% quarter-over-quarter to $382M.
Based on Carderock Capital Management's 13F filing for Q2 2024, filed 22 Jul 2024.